Haemostasis is a critical physiological process that maintains the balance between blood fluidity and clotting in the human body. This complex system involves a series of carefully regulated mechanisms that work together to prevent excessive blood loss when blood vessels are damaged, while also ensuring that blood remains liquid within the circulatory system.

The process of haemostasis can be broadly divided into three main stages: vascular spasm, platelet plug formation, and blood coagulation. These stages involve the interplay of blood vessels, platelets, coagulation factors, and various regulatory proteins. Understanding haemostasis is crucial in medicine, as disorders in this system can lead to either excessive bleeding or inappropriate clotting, both of which can have serious health consequences.

Stages of Haemostasis

The process of haemostasis involves three main stages:

Vascular spasm:

Immediate response to blood vessel injury
Damaged blood vessels constrict to reduce blood flow
Mediated by nervous reflexes and local factors
Temporary measure lasting about 30 minutes

Platelet plug formation:

Platelets adhere to exposed collagen at the injury site
Platelets activate and release chemicals to attract more platelets
Aggregation of platelets forms a loose plug
This stage is called primary haemostasis
Effective for small breaks in blood vessels

Blood coagulation (secondary haemostasis):

Involves a cascade of clotting factors
Triggered by tissue factor exposure or contact activation
Results in the formation of fibrin strands
Fibrin reinforces the platelet plug, creating a stable clot
This process takes longer but provides a stronger seal

Risks

Disruptions in the haemostasis process can lead to various risks and complications, broadly categorised into two main types:

1. Excessive bleeding disorders:

Haemophilia: Deficiency in clotting factors
Von Willebrand disease: Defective or deficient von Willebrand factor
Thrombocytopenia: Low platelet count
Vitamin K deficiency: Impaired production of certain clotting factors
Liver disease: Reduced production of clotting factors

Complications:

Prolonged bleeding from minor injuries
Spontaneous internal bleeding
Joint damage from recurrent bleeding
Increased risk of death from severe trauma

2. Excessive clotting disorders:

Thrombophilia: Inherited or acquired tendency to form clots
Factor V Leiden mutation: Resistance to activated protein C
Antiphospholipid syndrome: Autoimmune disorder causing increased clotting
Protein C or S deficiency: Lack of natural anticoagulants

Complications:

Deep vein thrombosis (DVT)
Pulmonary embolism
Stroke
Heart attack
Organ damage due to restricted blood flow

3. Other risks:

Disseminated intravascular coagulation (DIC): Abnormal activation of coagulation leading to both clotting and bleeding
Medication-induced imbalances: e.g., excessive anticoagulation leading to bleeding

How the Process Stops Blood Flow

The process of stopping blood flow through haemostasis involves a coordinated series of events:

Vascular spasm:

Injured blood vessels immediately constrict
Reduces blood flow to the damaged area
Helps bring the edges of the wound closer together

Platelet plug formation:

Platelets adhere to exposed collagen at the injury site
They become activated and release chemicals (e.g., ADP, thromboxane A2)
More platelets are attracted and aggregate
Forms a loose plug that temporarily seals the breach

Coagulation cascade:

Triggered by tissue factor exposure or contact activation
Series of enzymatic reactions involving clotting factors
Culminates in the formation of thrombin
Thrombin converts fibrinogen to fibrin

Fibrin clot formation:

Fibrin strands form a mesh-like structure
Reinforces the platelet plug
Traps red blood cells and other components
Creates a stable, solid clot

Clot retraction:

Platelets in the clot contract
Pulls the edges of the damaged vessel closer together
Strengthens the seal and reduces clot size

Diagnosis

Diagnosis and treatment of haemostatic disorders involve several steps:

Medical history:

Family history of bleeding or clotting disorders
Medication review (e.g., anticoagulants)
Symptoms and their onset

Physical examination:

Check for bruising, petechiae, or signs of thrombosis

Laboratory tests:

Complete blood count (CBC): Assesses platelet count
Prothrombin time (PT) and INR: Evaluate extrinsic pathway
Activated partial thromboplastin time (aPTT): Assesses intrinsic pathway
Fibrinogen level
D-dimer test: Indicates active clot formation/breakdown

Specialised tests:

Platelet function tests
Factor assays for specific clotting factors
Genetic testing for inherited disorders
Imaging studies:
Ultrasound, CT, or MRI to detect clots or bleeding

Treatment

For bleeding disorders:

Factor replacement therapy (e.g., for haemophilia)
Desmopressin (DDAVP) to increase factor VIII and von Willebrand factor
Antifibrinolytic agents (e.g., tranexamic acid)
Platelet transfusions for severe thrombocytopenia
Iron supplements for iron-deficiency anaemia

For clotting disorders:

Anticoagulants (e.g., heparin, warfarin, direct oral anticoagulants)
Antiplatelet drugs (e.g., aspirin, clopidogrel)
Thrombolytic therapy for acute thrombosis

Supportive care:

Compression stockings for DVT prevention
Regular monitoring of coagulation parameters
Lifestyle modifications (e.g., exercise, diet)

Surgical interventions:

In severe cases, such as embolectomy for pulmonary embolism

Treatment of underlying conditions

Managing diseases that affect haemostasis (e.g., liver disease, cancer)

Treatment is tailored to the specific disorder and its severity. Close monitoring and adjustment of therapy are often necessary to maintain the delicate balance between bleeding and clotting risks.

Haemostasis stops blood flow through a combination of vasoconstriction, platelet plug formation, and the coagulation process that reinforces the clot with fibrin. This integrated response is essential for preventing dangerous blood loss after an injury.

Reference links:

https://my.clevelandclinic.org/health/symptoms/21999-hemostasis
https://www.columbiadoctors.org/treatments-conditions/bleeding-coagulation-and-hemostasis-pediatric